Teza Capital Management LLC Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Teza Capital Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 33.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,296 shares of the healthcare conglomerate's stock after selling 1,178 shares during the quarter. Teza Capital Management LLC's holdings in UnitedHealth Group were worth $1,161,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $18.51 during mid-day trading on Wednesday, hitting $303.08. The company had a trading volume of 44,719,494 shares, compared to its average volume of 6,430,339. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The stock's 50 day moving average price is $464.33 and its 200-day moving average price is $510.17. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $274.93 billion, a P/E ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business earned $6.91 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.77%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Barclays decreased their price objective on shares of UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, Truist Financial reaffirmed a "buy" rating and set a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday. One analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $441.87.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John H. Noseworthy purchased 300 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now directly owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last three months. Corporate insiders own 0.33% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.